{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T10:32:43Z","timestamp":1779186763877,"version":"3.51.4"},"reference-count":99,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2007,10,1]],"date-time":"2007-10-01T00:00:00Z","timestamp":1191196800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2007,10,1]],"date-time":"2007-10-01T00:00:00Z","timestamp":1191196800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Nephrol"],"published-print":{"date-parts":[[2007,10]]},"DOI":"10.1038\/ncpneph0609","type":"journal-article","created":{"date-parts":[[2007,9,26]],"date-time":"2007-09-26T11:33:04Z","timestamp":1190806384000},"page":"540-550","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":62,"title":["Parvovirus-B19-associated complications in renal transplant recipients"],"prefix":"10.1038","volume":"3","author":[{"given":"Meryl","family":"Waldman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey B","family":"Kopp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BFncpneph0609_CR1","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1056\/NEJMra030840","volume":"350","author":"NS Young","year":"2004","unstructured":"Young NS and Brown KE (2004) Parvovirus B19. N Engl J Med 350: 586\u2013597","journal-title":"N Engl J Med"},{"key":"BFncpneph0609_CR2","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1128\/CMR.15.3.485-505.2002","volume":"15","author":"ED Heegaard","year":"2002","unstructured":"Heegaard ED and Brown KE (2002) Human parvovirus B19. Clin Microbiol Rev 15: 485\u2013505","journal-title":"Clin Microbiol Rev"},{"key":"BFncpneph0609_CR3","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1017\/S0950268899003817","volume":"124","author":"HA Kelly","year":"2000","unstructured":"Kelly HA  et al. (2000) The age-specific prevalence of human parvovirus immunity in Victoria, Australia compared with other parts of the world. Epidemiol Infect 124: 449\u2013457","journal-title":"Epidemiol Infect"},{"key":"BFncpneph0609_CR4","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1099\/00222615-25-2-151","volume":"25","author":"BJ Cohen","year":"1988","unstructured":"Cohen BJ and Buckley MM (1988) The prevalence of antibody to human parvovirus B19 in England and Wales. J Med Microbiol 25: 151\u2013153","journal-title":"J Med Microbiol"},{"key":"BFncpneph0609_CR5","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1006\/viro.2002.1585","volume":"301","author":"QT Nguyen","year":"2002","unstructured":"Nguyen QT  et al. (2002) Identification and characterization of a second novel human erythrovirus variant, A6. Virology 301: 374\u2013380","journal-title":"Virology"},{"key":"BFncpneph0609_CR6","doi-asserted-by":"crossref","first-page":"9124","DOI":"10.1128\/JVI.76.18.9124-9134.2002","volume":"76","author":"A Servant","year":"2002","unstructured":"Servant A  et al. (2002) Genetic diversity within human erythroviruses: identification of three genotypes. J Virol 76: 9124\u20139134","journal-title":"J Virol"},{"key":"BFncpneph0609_CR7","doi-asserted-by":"crossref","first-page":"6927","DOI":"10.1128\/JVI.02713-06","volume":"81","author":"A Ekman","year":"2007","unstructured":"Ekman A  et al. (2007) Biological and immunological relations among human parvovirus B19 genotypes 1\u20133. J Virol 81: 6927\u20136935","journal-title":"J Virol"},{"key":"BFncpneph0609_CR8","first-page":"71","volume":"118","author":"KE Brown","year":"2004","unstructured":"Brown KE (2004) Variants of B19. Dev Biol (Basel) 118: 71\u201377","journal-title":"Dev Biol (Basel)"},{"key":"BFncpneph0609_CR9","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1006\/viro.2002.1673","volume":"302","author":"K Hokynar","year":"2002","unstructured":"Hokynar K  et al. (2002) A new parvovirus genotype persistent in human skin. Virology 302: 224\u2013228","journal-title":"Virology"},{"key":"BFncpneph0609_CR10","doi-asserted-by":"crossref","first-page":"2627","DOI":"10.1128\/jvi.61.8.2627-2630.1987","volume":"61","author":"K Ozawa","year":"1987","unstructured":"Ozawa K and Young N (1987) Characterization of capsid and noncapsid proteins of B19 parvovirus propagated in human erythroid bone marrow cell cultures. J Virol 61: 2627\u20132630","journal-title":"J Virol"},{"key":"BFncpneph0609_CR11","doi-asserted-by":"crossref","first-page":"8443","DOI":"10.1128\/jvi.68.12.8443-8446.1994","volume":"68","author":"M Momoeda","year":"1994","unstructured":"Momoeda M  et al. (1994) A putative nucleoside triphosphate-binding domain in the nonstructural protein of B19 parvovirus is required for cytotoxicity. J Virol 68: 8443\u20138446","journal-title":"J Virol"},{"key":"BFncpneph0609_CR12","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1172\/JCI115812","volume":"89","author":"SJ Rosenfeld","year":"1992","unstructured":"Rosenfeld SJ  et al. (1992) Unique region of the minor capsid protein of human parvovirus B19 is exposed on the virion surface. J Clin Invest 89: 2023\u20132029","journal-title":"J Clin Invest"},{"key":"BFncpneph0609_CR13","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1126\/science.8211117","volume":"262","author":"KE Brown","year":"1993","unstructured":"Brown KE  et al. (1993) Erythrocyte P antigen: cellular receptor for B19 parvovirus. Science 262: 114\u2013117","journal-title":"Science"},{"key":"BFncpneph0609_CR14","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1093\/infdis\/172.5.1198","volume":"172","author":"LL Cooling","year":"1995","unstructured":"Cooling LL  et al. (1995) Multiple glycosphingolipids determine the tissue tropism of parvovirus B19. J Infect Dis 172: 1198\u20131205","journal-title":"J Infect Dis"},{"key":"BFncpneph0609_CR15","doi-asserted-by":"crossref","first-page":"3927","DOI":"10.1182\/blood-2003-05-1522","volume":"102","author":"KA Weigel-Kelley","year":"2003","unstructured":"Weigel-Kelley KA  et al. (2003) \u03b15\u03b21 integrin as a cellular coreceptor for human parvovirus B19: requirement of functional activation of \u03b21 integrin for viral entry. Blood 102: 3927\u20133933","journal-title":"Blood"},{"key":"BFncpneph0609_CR16","doi-asserted-by":"crossref","first-page":"3449","DOI":"10.1182\/blood-2005-02-0536","volume":"106","author":"Y Munakata","year":"2005","unstructured":"Munakata Y  et al. (2005) Ku80 autoantigen as a cellular coreceptor for human parvovirus B19 infection. Blood 106: 3449\u20133456","journal-title":"Blood"},{"key":"BFncpneph0609_CR17","doi-asserted-by":"crossref","first-page":"3018","DOI":"10.1128\/JVI.72.4.3018-3028.1998","volume":"72","author":"S Moffatt","year":"1998","unstructured":"Moffatt S  et al. (1998) Human parvovirus B19 nonstructural (NS1) protein induces apoptosis in erythroid lineage cells. J Virol 72: 3018\u20133028","journal-title":"J Virol"},{"key":"BFncpneph0609_CR18","doi-asserted-by":"crossref","first-page":"5941","DOI":"10.1128\/JVI.02430-05","volume":"80","author":"N Zhi","year":"2006","unstructured":"Zhi N  et al. (2006) Molecular and functional analyses of a human parvovirus B19 infectious clone demonstrates essential roles for NS1, VP1, and the 11-kilodalton protein in virus replication and infectivity. J Virol 80: 5941\u20135950","journal-title":"J Virol"},{"key":"BFncpneph0609_CR19","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1093\/infdis\/152.2.257","volume":"152","author":"MJ Anderson","year":"1985","unstructured":"Anderson MJ  et al. (1985) Experimental parvoviral infection in humans. J Infect Dis 152: 257\u2013265","journal-title":"J Infect Dis"},{"key":"BFncpneph0609_CR20","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1182\/blood.V75.3.603.603","volume":"75","author":"T Takahashi","year":"1990","unstructured":"Takahashi T  et al. (1990) Susceptibility of human erythropoietic cells to B19 parvovirus in vitro increases with differentiation. Blood 75: 603\u2013610","journal-title":"Blood"},{"key":"BFncpneph0609_CR21","doi-asserted-by":"crossref","first-page":"2915","DOI":"10.1128\/JVI.77.5.2915-2921.2003","volume":"77","author":"E Morita","year":"2003","unstructured":"Morita E  et al. (2003) Human parvovirus B19 nonstructural protein (NS1) induces cell cycle arrest at G1 phase. J Virol 77: 2915\u20132921","journal-title":"J Virol"},{"key":"BFncpneph0609_CR22","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1016\/0140-6736(93)91145-C","volume":"341","author":"GR Serjeant","year":"1993","unstructured":"Serjeant GR  et al. (1993) Human parvovirus infection in homozygous sickle cell disease. Lancet 341: 1237\u20131240","journal-title":"Lancet"},{"key":"BFncpneph0609_CR23","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1182\/blood.V67.5.1411.1411","volume":"67","author":"UM Saarinen","year":"1986","unstructured":"Saarinen UM  et al. (1986) Human parvovirus B19-induced epidemic acute red cell aplasia in patients with hereditary hemolytic anemia. Blood 67: 1411\u20131417","journal-title":"Blood"},{"key":"BFncpneph0609_CR24","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/S0369-8114(02)00302-4","volume":"50","author":"S Modrow","year":"2002","unstructured":"Modrow S and Dorsch S (2002) Antibody responses in parvovirus B19 infected patients. Pathol Biol (Paris) 50: 326\u2013331","journal-title":"Pathol Biol (Paris)"},{"key":"BFncpneph0609_CR25","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1099\/jmm.0.05485-0","volume":"53","author":"A Corcoran","year":"2004","unstructured":"Corcoran A and Doyle S (2004) Advances in the biology, diagnosis and host\u2013pathogen interactions of parvovirus B19. J Med Microbiol 53: 459\u2013475","journal-title":"J Med Microbiol"},{"key":"BFncpneph0609_CR26","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1002\/jmv.20513","volume":"78","author":"A Corcoran","year":"2006","unstructured":"Corcoran A  et al. (2006) Establishment of functional B cell memory against parvovirus B19 capsid proteins may be associated with resolution of persistent infection. J Med Virol 78: 125\u2013128","journal-title":"J Med Virol"},{"key":"BFncpneph0609_CR27","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/jmv.20514","volume":"78","author":"A Isa","year":"2006","unstructured":"Isa A  et al. (2006) Aberrant cellular immune responses in humans infected persistently with parvovirus B19. J Med Virol 78: 129\u2013133","journal-title":"J Med Virol"},{"key":"BFncpneph0609_CR28","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1128\/JVI.75.1.540-543.2001","volume":"75","author":"T Tolfvenstam","year":"2001","unstructured":"Tolfvenstam T  et al. (2001) Direct ex vivo measurement of CD8+ T-lymphocyte responses to human parvovirus B19. J Virol 75: 540\u2013543","journal-title":"J Virol"},{"key":"BFncpneph0609_CR29","doi-asserted-by":"crossref","first-page":"e343","DOI":"10.1371\/journal.pmed.0020343","volume":"2","author":"A Isa","year":"2005","unstructured":"Isa A  et al. (2005) Prolonged activation of virus-specific CD8+ T cells after acute B19 infection. PLoS Med 2: e343","journal-title":"PLoS Med"},{"key":"BFncpneph0609_CR30","doi-asserted-by":"crossref","first-page":"11209","DOI":"10.1128\/JVI.01173-06","volume":"80","author":"V Kasprowicz","year":"2006","unstructured":"Kasprowicz V  et al. (2006) Tracking of peptide-specific CD4+ T-cell responses after an acute resolving viral infection: a study of parvovirus B19. J Virol 80: 11209\u201311217","journal-title":"J Virol"},{"key":"BFncpneph0609_CR31","doi-asserted-by":"crossref","first-page":"12117","DOI":"10.1128\/JVI.79.18.12117-12121.2005","volume":"79","author":"O Norbeck","year":"2005","unstructured":"Norbeck O  et al. (2005) Sustained CD8+ T-cell responses induced after acute parvovirus B19 infection in humans. J Virol 79: 12117\u201312121","journal-title":"J Virol"},{"key":"BFncpneph0609_CR32","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/0166-0934(89)90146-8","volume":"26","author":"N Yaegashi","year":"1989","unstructured":"Yaegashi N  et al. (1989) Enzyme-linked immunosorbent assay for IgG and IgM antibodies against human parvovirus B19: use of monoclonal antibodies and viral antigen propagated in vitro. J Virol Methods 26: 171\u2013181","journal-title":"J Virol Methods"},{"key":"BFncpneph0609_CR33","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1128\/cdli.3.2.236-238.1996","volume":"3","author":"P Palmer","year":"1996","unstructured":"Palmer P  et al. (1996) Antibody response to human parvovirus B19 in patients with primary infection by immunoblot assay with recombinant proteins. Clin Diagn Lab Immunol 3: 236\u2013238","journal-title":"Clin Diagn Lab Immunol"},{"key":"BFncpneph0609_CR34","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1089\/088282401750234529","volume":"14","author":"E Zuffi","year":"2001","unstructured":"Zuffi E  et al. (2001) Identification of an immunodominant peptide in the parvovirus B19 VP1 unique region able to elicit a long-lasting immune response in humans. Viral Immunol 14: 151\u2013158","journal-title":"Viral Immunol"},{"key":"BFncpneph0609_CR35","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1111\/j.1600-0560.1995.tb01402.x","volume":"22","author":"M Takahashi","year":"1995","unstructured":"Takahashi M  et al. (1995) Human parvovirus B19 infection: immunohistochemical and electron microscopic studies of skin lesions. J Cutan Pathol 22: 168\u2013172","journal-title":"J Cutan Pathol"},{"key":"BFncpneph0609_CR36","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1053\/hp.2000.6714","volume":"31","author":"CM Magro","year":"2000","unstructured":"Magro CM  et al. (2000) The cutaneous manifestations of human parvovirus B19 infection. Hum Pathol 31: 488\u2013497","journal-title":"Hum Pathol"},{"key":"BFncpneph0609_CR37","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1002\/art.1780310218","volume":"31","author":"BA Dijkmans","year":"1988","unstructured":"Dijkmans BA  et al. (1988) Human parvovirus B19 DNA in synovial fluid. Arthritis Rheum 31: 279\u2013281","journal-title":"Arthritis Rheum"},{"key":"BFncpneph0609_CR38","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1002\/jmv.20158","volume":"74","author":"JR Kerr","year":"2004","unstructured":"Kerr JR  et al. (2004) Circulating cytokines and chemokines in acute symptomatic parvovirus B19 infection: negative association between levels of pro-inflammatory cytokines and development of B19-associated arthritis. J Med Virol 74: 147\u2013155","journal-title":"J Med Virol"},{"key":"BFncpneph0609_CR39","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1056\/NEJM198908243210807","volume":"321","author":"G Kurtzman","year":"1989","unstructured":"Kurtzman G  et al. (1989) Pure red-cell aplasia of 10 years' duration due to persistent parvovirus B19 infection and its cure with immunoglobulin therapy. N Engl J Med 321: 519\u2013523","journal-title":"N Engl J Med"},{"key":"BFncpneph0609_CR40","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1016\/S0140-6736(86)92245-2","volume":"2","author":"G Neild","year":"1986","unstructured":"Neild G  et al. (1986) Parvovirus infection after renal transplant. Lancet 2: 1226\u20131227","journal-title":"Lancet"},{"key":"BFncpneph0609_CR41","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1086\/504812","volume":"43","author":"AJ Eid","year":"2006","unstructured":"Eid AJ  et al. (2006) Parvovirus B19 infection after transplantation: a review of 98 cases. Clin Infect Dis 43: 40\u201348","journal-title":"Clin Infect Dis"},{"key":"BFncpneph0609_CR42","doi-asserted-by":"crossref","first-page":"2198","DOI":"10.1097\/00007890-200005270-00043","volume":"69","author":"ZR Zolnourian","year":"2000","unstructured":"Zolnourian ZR  et al. (2000) Parvovirus B19 in kidney transplant patients. Transplantation 69: 2198\u20132202","journal-title":"Transplantation"},{"key":"BFncpneph0609_CR43","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1111\/j.1399-0012.2005.00415.x","volume":"19","author":"CS Ki","year":"2005","unstructured":"Ki CS  et al. (2005) Incidence and clinical significance of human parvovirus B19 infection in kidney transplant recipients. Clin Transplant 19: 751\u2013755","journal-title":"Clin Transplant"},{"key":"BFncpneph0609_CR44","first-page":"152","volume":"10","author":"E Bertoni","year":"1997","unstructured":"Bertoni E  et al. (1997) Aplastic anemia due to B19 parvovirus infection in cadaveric renal transplant recipients: an underestimated infectious disease in the immunocompromised host. J Nephrol 10: 152\u2013156","journal-title":"J Nephrol"},{"key":"BFncpneph0609_CR45","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1034\/j.1399-3062.2002.01007.x","volume":"4","author":"A Yango Jr","year":"2002","unstructured":"Yango A Jr  et al. (2002) Donor-transmitted parvovirus infection in a kidney transplant recipient presenting as pancytopenia and allograft dysfunction. Transpl Infect Dis 4: 163\u2013166","journal-title":"Transpl Infect Dis"},{"key":"BFncpneph0609_CR46","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1681\/ASN.V1161132","volume":"11","author":"L Murer","year":"2000","unstructured":"Murer L  et al. (2000) Thrombotic microangiopathy associated with parvovirus B19 infection after renal transplantation. J Am Soc Nephrol 11: 1132\u20131137","journal-title":"J Am Soc Nephrol"},{"key":"BFncpneph0609_CR47","first-page":"1462","volume":"10","author":"E Bertoni","year":"1995","unstructured":"Bertoni E  et al. (1995) Severe aplastic anaemia due to B19 parvovirus infection in renal transplant recipient. Nephrol Dial Transplant 10: 1462\u20131463","journal-title":"Nephrol Dial Transplant"},{"key":"BFncpneph0609_CR48","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1093\/ndt\/11.7.1367","volume":"11","author":"I Sturm","year":"1996","unstructured":"Sturm I  et al. (1996) Chronic parvovirus B19 infection-associated pure red cell anaemia in a kidney transplant recipient. Nephrol Dial Transplant 11: 1367\u20131370","journal-title":"Nephrol Dial Transplant"},{"key":"BFncpneph0609_CR49","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/j.1600-0609.1995.tb01634.x","volume":"54","author":"N Uemura","year":"1995","unstructured":"Uemura N  et al. (1995) Pure red cell aplasia caused by parvovirus B19 infection in a renal transplant recipient. Eur J Haematol 54: 68\u201369","journal-title":"Eur J Haematol"},{"key":"BFncpneph0609_CR50","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S1386-6532(02)00104-X","volume":"26","author":"R Cavallo","year":"2003","unstructured":"Cavallo R  et al. (2003) B19 virus infection in renal transplant recipients. J Clin Virol 26: 361\u2013368","journal-title":"J Clin Virol"},{"key":"BFncpneph0609_CR51","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/S0041-1345(96)00147-9","volume":"29","author":"E Bertoni","year":"1997","unstructured":"Bertoni E  et al. (1997) Unusual incidence of aplastic anaemia due to B-19 parvovirus infection in renal transplant recipients. Transplant Proc 29: 818\u2013819","journal-title":"Transplant Proc"},{"key":"BFncpneph0609_CR52","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/j.1600-6143.2005.01139.x","volume":"6","author":"O Egbuna","year":"2006","unstructured":"Egbuna O  et al. (2006) A cluster of parvovirus B19 infections in renal transplant recipients: a prospective case series and review of the literature. Am J Transplant 6: 225\u2013231","journal-title":"Am J Transplant"},{"key":"BFncpneph0609_CR53","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.1016\/j.transproceed.2006.06.116","volume":"38","author":"E Renoult","year":"2006","unstructured":"Renoult E  et al. (2006) Recurrent anemia in kidney transplant recipients with parvovirus B19 infection. Transplant Proc 38: 2321\u20132323","journal-title":"Transplant Proc"},{"key":"BFncpneph0609_CR54","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0046-8177(00)80215-4","volume":"31","author":"TW Crook","year":"2000","unstructured":"Crook TW  et al. (2000) Unusual bone marrow manifestations of parvovirus B19 infection in immunocompromised patients. Hum Pathol 31: 161\u2013168","journal-title":"Hum Pathol"},{"key":"BFncpneph0609_CR55","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1080\/08860220500461302","volume":"28","author":"P Onguru","year":"2006","unstructured":"Onguru P  et al. (2006) Glomerulonephritis associating parvovirus B19 infection. Ren Fail 28: 85\u201388","journal-title":"Ren Fail"},{"key":"BFncpneph0609_CR56","doi-asserted-by":"crossref","first-page":"249","DOI":"10.5414\/CNP64249","volume":"64","author":"N Ieiri","year":"2005","unstructured":"Ieiri N  et al. (2005) Characteristics of acute glomerulonephritis associated with human parvovirus B19 infection. Clin Nephrol 64: 249\u2013257","journal-title":"Clin Nephrol"},{"key":"BFncpneph0609_CR57","first-page":"246","volume":"57","author":"Y Iwafuchi","year":"2002","unstructured":"Iwafuchi Y  et al. (2002) Acute endocapillary proliferative glomerulonephritis associated with human parvovirus B19 infection. Clin Nephrol 57: 246\u2013250","journal-title":"Clin Nephrol"},{"key":"BFncpneph0609_CR58","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1007\/s00467-002-1056-2","volume":"18","author":"Y Ohtomo","year":"2003","unstructured":"Ohtomo Y  et al. (2003) Nephrotic syndrome associated with human parvovirus B19 infection. Pediatr Nephrol 18: 280\u2013282","journal-title":"Pediatr Nephrol"},{"key":"BFncpneph0609_CR59","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1053\/ajkd.2000.17718","volume":"36","author":"A Komatsuda","year":"2000","unstructured":"Komatsuda A  et al. (2000) Endocapillary proliferative glomerulonephritis in a patient with parvovirus B19 infection. Am J Kidney Dis 36: 851\u2013854","journal-title":"Am J Kidney Dis"},{"key":"BFncpneph0609_CR60","doi-asserted-by":"crossref","first-page":"69","DOI":"10.5414\/CNP57069","volume":"57","author":"Y Mori","year":"2002","unstructured":"Mori Y  et al. (2002) Association of parvovirus B19 infection with acute glomerulonephritis in healthy adults: case report and review of the literature. Clin Nephrol 57: 69\u201373","journal-title":"Clin Nephrol"},{"key":"BFncpneph0609_CR61","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1159\/000046086","volume":"89","author":"S Takeda","year":"2001","unstructured":"Takeda S  et al. (2001) Renal involvement induced by human parvovirus B19 infection. Nephron 89: 280\u2013285","journal-title":"Nephron"},{"key":"BFncpneph0609_CR62","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1086\/317556","volume":"32","author":"G Taylor","year":"2001","unstructured":"Taylor G  et al. (2001) Renal involvement of human parvovirus B19 in an immunocompetent host. Clin Infect Dis 32: 167\u2013169","journal-title":"Clin Infect Dis"},{"key":"BFncpneph0609_CR63","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S0140-6736(95)91324-6","volume":"346","author":"KJ Wierenga","year":"1995","unstructured":"Wierenga KJ  et al. (1995) Glomerulonephritis after human parvovirus infection in homozygous sickle-cell disease. Lancet 346: 475\u2013476","journal-title":"Lancet"},{"key":"BFncpneph0609_CR64","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1007\/s004670050622","volume":"13","author":"A Tolaymat","year":"1999","unstructured":"Tolaymat A  et al. (1999) Parvovirus glomerulonephritis in a patient with sickle cell disease. Pediatr Nephrol 13: 340\u2013342","journal-title":"Pediatr Nephrol"},{"key":"BFncpneph0609_CR65","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1046\/j.1523-1755.2001.00727.x","volume":"59","author":"A Moudgil","year":"2001","unstructured":"Moudgil A  et al. (2001) Association of parvovirus B19 infection with idiopathic collapsing glomerulopathy. Kidney Int 59: 2126\u20132133","journal-title":"Kidney Int"},{"key":"BFncpneph0609_CR66","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1034\/j.1600-6143.2002.20505.x","volume":"2","author":"NR Barsoum","year":"2002","unstructured":"Barsoum NR  et al. (2002) Treatment of parvovirus B-19 (PV B-19) infection allows for successful kidney transplantation without disease recurrence. Am J Transplant 2: 425\u2013428","journal-title":"Am J Transplant"},{"key":"BFncpneph0609_CR67","doi-asserted-by":"crossref","first-page":"2607","DOI":"10.1093\/ndt\/gfl225","volume":"21","author":"S Swaminathan","year":"2006","unstructured":"Swaminathan S  et al. (2006) Collapsing and non-collapsing focal segmental glomerulosclerosis in kidney transplants. Nephrol Dial Transplant 21: 2607\u20132614","journal-title":"Nephrol Dial Transplant"},{"key":"BFncpneph0609_CR68","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1093\/ndt\/14.2.469","volume":"14","author":"YK Keung","year":"1999","unstructured":"Keung YK  et al. (1999) Concomitant parvovirus B19 and cytomegalovirus infections after living-related renal transplantation. Nephrol Dial Transplant 14: 469\u2013471","journal-title":"Nephrol Dial Transplant"},{"key":"BFncpneph0609_CR69","doi-asserted-by":"crossref","first-page":"4306","DOI":"10.1016\/j.transproceed.2005.11.052","volume":"37","author":"MR Becker","year":"2005","unstructured":"Becker MR  et al. (2005) Renal anemia aggravated by long-term parvovirus B19 and cytomegalovirus infection in a renal transplant patient: case report and evaluation of B19 seroprevalence in dialysis patients. Transplant Proc 37: 4306\u20134308","journal-title":"Transplant Proc"},{"key":"BFncpneph0609_CR70","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1034\/j.1399-0012.1999.t01-1-130103.x","volume":"13","author":"S Marchand","year":"1999","unstructured":"Marchand S  et al. (1999) Human parvovirus B19 infection in organ transplant recipients. Clin Transplant 13: 17\u201324","journal-title":"Clin Transplant"},{"key":"BFncpneph0609_CR71","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/BF00866361","volume":"8","author":"N Al-Khaldi","year":"1994","unstructured":"Al-Khaldi N  et al. (1994) Dual infection with human herpesvirus type 6 and parvovirus B19 in a renal transplant recipient. Pediatr Nephrol 8: 349\u2013350","journal-title":"Pediatr Nephrol"},{"key":"BFncpneph0609_CR72","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.cca.2006.04.018","volume":"372","author":"D Peterlana","year":"2006","unstructured":"Peterlana D  et al. (2006) Serologic and molecular detection of human Parvovirus B19 infection. Clin Chim Acta 372: 14\u201323","journal-title":"Clin Chim Acta"},{"key":"BFncpneph0609_CR73","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1093\/infdis\/172.5.1360","volume":"172","author":"M Musiani","year":"1995","unstructured":"Musiani M  et al. (1995) Parvovirus B19 clearance from peripheral blood after acute infection. J Infect Dis 172: 1360\u20131363","journal-title":"J Infect Dis"},{"key":"BFncpneph0609_CR74","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0369-8114(02)00307-3","volume":"50","author":"M Soderlund-Venermo","year":"2002","unstructured":"Soderlund-Venermo M  et al. (2002) Persistence of human parvovirus B19 in human tissues. Pathol Biol (Paris) 50: 307\u2013316","journal-title":"Pathol Biol (Paris)"},{"key":"BFncpneph0609_CR75","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1128\/JCM.42.5.2013-2019.2004","volume":"42","author":"K Hokynar","year":"2004","unstructured":"Hokynar K  et al. (2004) Detection and differentiation of human parvovirus variants by commercial quantitative real-time PCR tests. J Clin Microbiol 42: 2013\u20132019","journal-title":"J Clin Microbiol"},{"key":"BFncpneph0609_CR76","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1002\/jmv.20251","volume":"75","author":"L Liefeldt","year":"2005","unstructured":"Liefeldt L  et al. (2005) Recurrent high level parvovirus B19\/genotype 2 viremia in a renal transplant recipient analyzed by real-time PCR for simultaneous detection of genotypes 1 to 3. J Med Virol 75: 161\u2013169","journal-title":"J Med Virol"},{"key":"BFncpneph0609_CR77","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1093\/ndt\/17.10.1840","volume":"17","author":"L Liefeldt","year":"2002","unstructured":"Liefeldt L  et al. (2002) Eradication of parvovirus B19 infection after renal transplantation requires reduction of immunosuppression and high-dose immunoglobulin therapy. Nephrol Dial Transplant 17: 1840\u20131842","journal-title":"Nephrol Dial Transplant"},{"key":"BFncpneph0609_CR78","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1034\/j.1399-0012.2000.140612.x","volume":"14","author":"D Geetha","year":"2000","unstructured":"Geetha D  et al. (2000) Pure red cell aplasia caused by Parvovirus B19 infection in solid organ transplant recipients: a case report and review of literature. Clin Transplant 14: 586\u2013591","journal-title":"Clin Transplant"},{"key":"BFncpneph0609_CR79","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1111\/j.1399-3046.2005.00379.x","volume":"9","author":"MM Subtirelu","year":"2005","unstructured":"Subtirelu MM  et al. (2005) Acute renal failure in a pediatric kidney allograft recipient treated with intravenous immunoglobulin for parvovirus B19 induced pure red cell aplasia. Pediatr Transplant 9: 801\u2013804","journal-title":"Pediatr Transplant"},{"key":"BFncpneph0609_CR80","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1053\/ajkd.2002.35899","volume":"40","author":"D Tsinalis","year":"2002","unstructured":"Tsinalis D  et al. (2002) Acute renal failure in a renal allograft recipient treated with intravenous immunoglobulin. Am J Kidney Dis 40: 667\u2013670","journal-title":"Am J Kidney Dis"},{"key":"BFncpneph0609_CR81","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1093\/qjmed\/93.11.751","volume":"93","author":"JB Levy","year":"2000","unstructured":"Levy JB and Pusey CD (2000) Nephrotoxicity of intravenous immunoglobulin. QJM 93: 751\u2013755","journal-title":"QJM"},{"key":"BFncpneph0609_CR82","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1016\/S0041-1345(00)01515-3","volume":"32","author":"H Shimmura","year":"2000","unstructured":"Shimmura H  et al. (2000) Discontinuation of immunosuppressive antimetabolite for parvovirus B19-associated anemia in kidney transplant patients. Transplant Proc 32: 1967\u20131970","journal-title":"Transplant Proc"},{"key":"BFncpneph0609_CR83","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1016\/S0272-6386(99)70021-1","volume":"34","author":"TY Wong","year":"1999","unstructured":"Wong TY  et al. (1999) Parvovirus B19 infection causing red cell aplasia in renal transplantation on tacrolimus. Am J Kidney Dis 34: 1132\u20131136","journal-title":"Am J Kidney Dis"},{"key":"BFncpneph0609_CR84","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1080\/003655402753395247","volume":"34","author":"SH Choi","year":"2002","unstructured":"Choi SH  et al. (2002) A case of persistent anemia in a renal transplant recipient: association with parvovirus B19 infection. Scand J Infect Dis 34: 71\u201375","journal-title":"Scand J Infect Dis"},{"key":"BFncpneph0609_CR85","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/j.1600-6143.2004.00636.x","volume":"5","author":"PS Gregoor","year":"2005","unstructured":"Gregoor PS and Weimar W (2005) Tacrolimus and pure red-cell aplasia. Am J Transplant 5: 195\u2013196","journal-title":"Am J Transplant"},{"key":"BFncpneph0609_CR86","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1111\/j.1432-2277.2005.00247.x","volume":"19","author":"N Arzouk","year":"2006","unstructured":"Arzouk N  et al. (2006) Parvovirus B19-induced anemia in renal transplantation: a role for rHuEPO in resistance to classical treatment. Transpl Int 19: 166\u2013169","journal-title":"Transpl Int"},{"key":"BFncpneph0609_CR87","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s00282-997-0199-9","volume":"39","author":"J Wicki","year":"1997","unstructured":"Wicki J  et al. (1997) Parvovirus [correction of Parovirus] B19-induced red cell aplasia in solid-organ transplant recipients: two case reports and review of the literature. Hematol Cell Ther 39: 199\u2013204","journal-title":"Hematol Cell Ther"},{"key":"BFncpneph0609_CR88","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1136\/jcp.56.10.725","volume":"56","author":"JR Kerr","year":"2003","unstructured":"Kerr JR  et al. (2003) Cytokine gene polymorphisms associated with symptomatic parvovirus B19 infection. J Clin Pathol 56: 725\u2013727","journal-title":"J Clin Pathol"},{"key":"BFncpneph0609_CR89","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1097\/00002281-200007000-00010","volume":"12","author":"TL Moore","year":"2000","unstructured":"Moore TL (2000) Parvovirus-associated arthritis. Curr Opin Rheumatol 12: 289\u2013294","journal-title":"Curr Opin Rheumatol"},{"key":"BFncpneph0609_CR90","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1136\/ard.59.9.672","volume":"59","author":"JR Kerr","year":"2000","unstructured":"Kerr JR (2000) Pathogenesis of human parvovirus B19 in rheumatic disease. Ann Rheum Dis 59: 672\u2013683","journal-title":"Ann Rheum Dis"},{"key":"BFncpneph0609_CR91","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1086\/499599","volume":"193","author":"J Lu","year":"2006","unstructured":"Lu J  et al. (2006) Activation of synoviocytes by the secreted phospholipase A2 motif in the VP1-unique region of parvovirus B19 minor capsid protein. J Infect Dis 193: 582\u2013590","journal-title":"J Infect Dis"},{"key":"BFncpneph0609_CR92","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.reprotox.2005.01.006","volume":"21","author":"Z Ergaz","year":"2006","unstructured":"Ergaz Z and Ornoy A (2006) Parvovirus B19 in pregnancy. Reprod Toxicol 21: 421\u2013435","journal-title":"Reprod Toxicol"},{"key":"BFncpneph0609_CR93","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/S0163-4453(99)90026-9","volume":"38","author":"N Yaegashi","year":"1999","unstructured":"Yaegashi N  et al. (1999) Serologic study of human parvovirus B19 infection in pregnancy in Japan. J Infect 38: 30\u201335","journal-title":"J Infect"},{"key":"BFncpneph0609_CR94","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1002\/pd.940","volume":"24","author":"M Enders","year":"2004","unstructured":"Enders M  et al. (2004) Fetal morbidity and mortality after acute human parvovirus B19 infection in pregnancy: prospective evaluation of 1018 cases. Prenat Diagn 24: 513\u2013518","journal-title":"Prenat Diagn"},{"key":"BFncpneph0609_CR95","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1093\/ndt\/15.9.1486","volume":"15","author":"PC Lee","year":"2000","unstructured":"Lee PC  et al. (2000) Parvovirus B19-related acute hepatitis in an immunosuppressed kidney transplant. Nephrol Dial Transplant 15: 1486\u20131488","journal-title":"Nephrol Dial Transplant"},{"key":"BFncpneph0609_CR96","doi-asserted-by":"crossref","first-page":"2420","DOI":"10.1093\/ndt\/16.12.2420","volume":"16","author":"YS Shan","year":"2001","unstructured":"Shan YS  et al. (2001) Fibrosing cholestatic hepatitis possibly related to persistent parvovirus B19 infection in a renal transplant recipient. Nephrol Dial Transplant 16: 2420\u20132422","journal-title":"Nephrol Dial Transplant"},{"key":"BFncpneph0609_CR97","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1111\/j.1399-3046.2006.00599.x","volume":"10","author":"M Laurenz","year":"2006","unstructured":"Laurenz M  et al. (2006) Severe parvovirus B19 encephalitis after renal transplantation. Pediatr Transplant 10: 978\u2013981","journal-title":"Pediatr Transplant"},{"key":"BFncpneph0609_CR98","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/s00467-004-1736-1","volume":"20","author":"I Bilge","year":"2005","unstructured":"Bilge I  et al. (2005) Central nervous system vasculitis secondary to parvovirus B19 infection in a pediatric renal transplant patient. Pediatr Nephrol 20: 529\u2013533","journal-title":"Pediatr Nephrol"},{"key":"BFncpneph0609_CR99","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1097\/00007890-199712270-00037","volume":"64","author":"A Moudgil","year":"1997","unstructured":"Moudgil A  et al. (1997) Parvovirus B19 infection-related complications in renal transplant recipients: treatment with intravenous immunoglobulin. Transplantation 64: 1847\u20131850","journal-title":"Transplantation"}],"container-title":["Nature Clinical Practice Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/ncpneph0609.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/ncpneph0609","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/ncpneph0609.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,29]],"date-time":"2022-07-29T19:04:15Z","timestamp":1659121455000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/ncpneph0609"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,10]]},"references-count":99,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2007,10]]}},"alternative-id":["BFncpneph0609"],"URL":"https:\/\/doi.org\/10.1038\/ncpneph0609","relation":{},"ISSN":["1745-8323","1745-8331"],"issn-type":[{"value":"1745-8323","type":"print"},{"value":"1745-8331","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,10]]},"assertion":[{"value":"19 April 2007","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2007","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}